open access

Vol 10, Supp. A (2019)
Case report
Get Citation

The coexistence of Hodgkin lymphoma and myelofibrosis in a patient treated with ruxolitinib

Maria Cioch1
DOI: 10.5603/Hem.2019.0008
Affiliations
  1. Katedra i Klinika Hematoonkologii i Transplantacji Szpiku, Uniwersytet Medyczny w Lublinie, Lubline, Poland

open access

Vol 10, Supp. A (2019)
CASE REPORTS

Abstract

Philadelphia-negative myeloproliferative neoplasms are associated with increased risk of lymphoid neoplasms. In this article a female patient with essential thrombocythemia and Hodgkin lymphoma was reported. When remission of lymphoma was obtained secondary myelofibrosis was developed. Therapy with ruxolitinib resulted in resolution of constitutional symptoms and reduction of spleen volume in a short period of time.

Abstract

Philadelphia-negative myeloproliferative neoplasms are associated with increased risk of lymphoid neoplasms. In this article a female patient with essential thrombocythemia and Hodgkin lymphoma was reported. When remission of lymphoma was obtained secondary myelofibrosis was developed. Therapy with ruxolitinib resulted in resolution of constitutional symptoms and reduction of spleen volume in a short period of time.

Get Citation

Keywords

essential thrombocythemia, secondary myelofibrosis, Hodgkin lymphoma, ruxolitinib

About this article
Title

The coexistence of Hodgkin lymphoma and myelofibrosis in a patient treated with ruxolitinib

Journal

Hematology in Clinical Practice

Issue

Vol 10, Supp. A (2019)

Article type

Case report

Pages

19-22

DOI

10.5603/Hem.2019.0008

Keywords

essential thrombocythemia
secondary myelofibrosis
Hodgkin lymphoma
ruxolitinib

Authors

Maria Cioch

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.